These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 3160458)
21. Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy. Nicholson JK; McDougal JS; Spira TJ; Cross GD; Jones BM; Reinherz EL J Clin Invest; 1984 Jan; 73(1):191-201. PubMed ID: 6228564 [TBL] [Abstract][Full Text] [Related]
22. Diversity of clinical spectrum of HTLV-III infection. Valle SL; Saxinger C; Ranki A; Antonen J; Suni J; Lähdevirta J; Krohn K Lancet; 1985 Feb; 1(8424):301-4. PubMed ID: 2857362 [TBL] [Abstract][Full Text] [Related]
26. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses. Margolick JB; Volkman DJ; Folks TM; Fauci AS J Immunol; 1987 Mar; 138(6):1719-23. PubMed ID: 3493285 [TBL] [Abstract][Full Text] [Related]
27. [Thrombopenic purpura in a group of addicts addicted to parenteral drugs with anti-HTLV-III/LAV antibodies and inversion of the T-helper/T-suppressor cell quotient]. Aguilar Ligorti E; Guix García J; Ample Guillén I; Balaguer Martínez JV; Marugán de la Concha I; García-Conde Bru J Sangre (Barc); 1986; 31(4):401-10. PubMed ID: 2947340 [No Abstract] [Full Text] [Related]
28. Acute HTLV-III infection. A case followed from onset to seroconversion. Biggs B; Newton-John HF Med J Aust; 1986 May; 144(10):545-7. PubMed ID: 3012294 [TBL] [Abstract][Full Text] [Related]
29. Normal T cell subsets in homosexual men living in a community without endemic AIDS. Rush TJ; Betts RF; Saxinger C; Cowell SA; Ryan DH; Yang CC; Steigbigel RT Am J Med; 1986 Oct; 81(4):584-90. PubMed ID: 2945432 [TBL] [Abstract][Full Text] [Related]
30. [Epstein-Barr virus-specific immunity in asymptomatic carriers of human T-cell leukemia virus type 1]. Kwon KW Hokkaido Igaku Zasshi; 1995 Mar; 70(2):315-28. PubMed ID: 7774883 [TBL] [Abstract][Full Text] [Related]
31. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767 [TBL] [Abstract][Full Text] [Related]
32. Human T lymphotropic virus type I (HTLV-I)-specific T helper cell responses from HTLV-I seronegative patients with chronic myelopathy and MS in Japan. Nishimura M; Jacobson S; Uchiyama T; Ohta M; Saida T Mult Scler; 1996 Feb; 1(4):200-3. PubMed ID: 9345434 [TBL] [Abstract][Full Text] [Related]
33. The relationship of abnormalities of cellular immunity to antibodies to HTLV-III in homosexual men. Dobozin BS; Judson FN; Cohn DL; Penley KA; Rickmann PE; Blaser MJ; Sarin PS; Weiss SH; Kirkpatrick CH Cell Immunol; 1986 Mar; 98(1):156-71. PubMed ID: 3017581 [TBL] [Abstract][Full Text] [Related]
34. Induction of a T-cell mediated suppressor activity by soluble products from antigen-specific helper/inducer human T-cell lines. Fischer A; Beverley P; Feldmann M; Smith S Immunology; 1983 Jan; 48(1):177-86. PubMed ID: 6217152 [TBL] [Abstract][Full Text] [Related]
35. Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study. Melbye M; Biggar RJ; Ebbesen P; Neuland C; Goedert JJ; Faber V; Lorenzen I; Skinhøj P; Gallo RC; Blattner WA Ann Intern Med; 1986 Apr; 104(4):496-500. PubMed ID: 3006568 [TBL] [Abstract][Full Text] [Related]
36. One year follow-up study of T-cell subsets and incidence of seropositivity for HTLV-I and HTLV-III antibodies in patients treated "on demand" or sporadically with clotting concentrates. Rodeghiero F; Castaman GC; Chisesi T; De Rossi A; Dalla Gassa O; Del Mistro A; Dini E; Castronovo S; Pornaro E; Chieco-Bianchi L Thromb Haemost; 1985 Oct; 54(3):665-8. PubMed ID: 3003954 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of HTLV-III/LAV antibody in selected populations in Thailand. Wangroongsarb Y; Weniger BG; Wasi C; Traisupa A; Kunasol P; Rojanapithayakorn W; Fucharoen S Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):517-20. PubMed ID: 3869739 [TBL] [Abstract][Full Text] [Related]
38. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes. Faure M; Thivolet J J Clin Immunol; 1982 Jul; 2(3 Suppl):103S-110S. PubMed ID: 6215423 [TBL] [Abstract][Full Text] [Related]
39. Natural killer cell function and modulation by alpha IFN and IL2 in AIDS patients and prodromal subjects. Lew F; Tsang P; Solomon S; Selikoff IJ; Bekesi JG J Clin Lab Immunol; 1984 Jul; 14(3):115-21. PubMed ID: 6237206 [TBL] [Abstract][Full Text] [Related]
40. [Analysis of antibodies to human T-lymphotropic type III virus (anti-HTLV III) in a population at high risk for AIDS in Yugoslavia]. Burek V; Sakoman S; Hudolin V; Kovać D; Ficović P; Cepelja Z; Petricević I; Schönwald S; Soldo I; Borcić D Lijec Vjesn; 1987 Jun; 109(6):216-9. PubMed ID: 3477674 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]